Works by Apel, Arie


Results: 17
    1
    2
    3
    4
    5

    Midostaurin in Combination with Intensive Chemotherapy is Safe and Associated with Improved Remission Rates and Higher Transplantation Rates in First Remission-A Multi-Center Historical Control Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S208, doi. 10.1016/j.clml.2019.07.072
    By:
    • Berger, Tamar;
    • Uri, Rozovski;
    • Moshe, Yakir;
    • Yaari, Shilo;
    • Frisch, Avraham;
    • Hellmann, Ilana;
    • Apel, Arie;
    • Aviram, Adina;
    • Koren-Michowitz, Maya;
    • Yeshurun, Moshe;
    • Ram, Ron;
    • Raanani, Pia;
    • Ofran, Yishai;
    • Wolach, Ofir
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1.

    Published in:
    British Journal of Haematology, 2017, v. 176, n. 6, p. 929, doi. 10.1111/bjh.14493
    By:
    • Bar ‐ Natan, Michal;
    • Stroopinsky, Dina;
    • Luptakova, Katarina;
    • Coll, Maxwell D.;
    • Apel, Arie;
    • Rajabi, Hasan;
    • Pyzer, Athalia R.;
    • Palmer, Kristen;
    • Reagan, Michaela R.;
    • Nahas, Myrna R.;
    • Karp Leaf, Rebecca;
    • Jain, Salvia;
    • Arnason, Jon;
    • Ghobrial, Irene M.;
    • Anderson, Kenneth C.;
    • Kufe, Donald;
    • Rosenblatt, Jacalyn;
    • Avigan, David
    Publication type:
    Article
    12
    13
    14
    15

    Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 7, p. 790, doi. 10.1002/ajh.26190
    By:
    • Apel, Arie;
    • Moshe, Yakir;
    • Ofran, Yishai;
    • Gural, Alexander;
    • Wolach, Ofir;
    • Ganzel, Chezi;
    • Canaani, Jonathan;
    • Zektser, Miri;
    • Duek, Adrian;
    • Stemer, Galia;
    • Hellman, Ilana;
    • Basood, May;
    • Frisch, Avraham;
    • Leibovitch, Chiya;
    • Koren‐Michowitz, Maya
    Publication type:
    Article
    16

    Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 10, p. 1011, doi. 10.1002/ajh.24827
    By:
    • Shimoni, Avichai;
    • Vago, Luca;
    • Bernardi, Massimo;
    • Yerushalmi, Ronit;
    • Peccatori, Jacopo;
    • Greco, Raffaella;
    • Shem-Tov, Noga;
    • Lo Russo, Alessandro;
    • Danylesko, Ivetta;
    • Apel, Arie;
    • Bonini, Chiara;
    • Lupo Stanghellini, Maria Teresa;
    • Nagler, Arnon;
    • Ciceri, Fabio
    Publication type:
    Article
    17

    Venetoclax is safe and efficacious in relapsed/refractory AML.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 9, p. 2221, doi. 10.1080/10428194.2020.1761964
    By:
    • Ganzel, Chezi;
    • Ram, Ron;
    • Gural, Alexander;
    • Wolach, Ofir;
    • Gino-Moor, Sharon;
    • Vainstein, Vladimir;
    • Nachmias, Boaz;
    • Apel, Arie;
    • Koren-Michowitz, Maya;
    • Pasvolsky, Oren;
    • Yerushalmi, Ronit;
    • Danylesko, Ivetta;
    • Cohen, Yosef;
    • Peretz, Galit;
    • Moshe, Yakir;
    • Zektser, Miri;
    • Yeganeh, Shay;
    • Rowe, Jacob M.;
    • Ofran, Yishai
    Publication type:
    Article